Healthcare -
Biotechnology - NASDAQ - US
$ 1.09
-0.909 %
$ 227 M
Market Cap
-1.54
P/E
SGMO - DEPRECIATION & AMORTIZATION
Depreciation & Amortization SGMO - Sangamo Therapeutics, Inc.
22.2 M
LAST VALUE
12.17%
2 YEAR CAGR
56.56%
5 YEAR CAGR
44.25%
10 YEAR CAGR